Castle Biosciences, Inc. (CSTL)
33.79
-0.71
(-2.06%)
USD |
NASDAQ |
Nov 13, 16:00
33.77
-0.02
(-0.06%)
After-Hours: 19:59
Castle Biosciences Shareholders Equity (Quarterly) : 478.44M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 478.44M |
| June 30, 2026 | 470.03M |
| March 31, 2026 | 461.42M |
| December 31, 2025 | 470.87M |
| September 30, 2025 | 467.05M |
| June 30, 2025 | 455.38M |
| March 31, 2025 | 440.31M |
| December 31, 2024 | 455.84M |
| September 30, 2024 | 441.06M |
| June 30, 2024 | 423.89M |
| March 31, 2024 | 402.46M |
| December 31, 2023 | 391.27M |
| September 30, 2023 | 385.78M |
| June 30, 2023 | 378.77M |
| March 31, 2023 | 385.15M |
| December 31, 2022 | 399.15M |
| Date | Value |
|---|---|
| September 30, 2022 | 411.43M |
| June 30, 2022 | 421.66M |
| March 31, 2022 | 397.34M |
| December 31, 2021 | 411.74M |
| September 30, 2021 | 411.71M |
| June 30, 2021 | 415.92M |
| March 31, 2021 | 418.59M |
| December 31, 2020 | 415.69M |
| September 30, 2020 | 166.56M |
| June 30, 2020 | 157.62M |
| March 31, 2020 | 87.93M |
| December 31, 2019 | 85.11M |
| September 30, 2019 | 82.34M |
| June 30, 2019 | -5.095M |
| March 31, 2019 | -4.381M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| RadNet, Inc. | 1.121B |
| Lumexa Imaging Holdings, Inc. | 634.08M |
| Quest Diagnostics, Inc. | 7.632B |
| Labcorp Holdings, Inc. | 8.848B |
| OPKO Health, Inc. | 1.116B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 579.41M |
| Total Liabilities (Quarterly) | 100.96M |
| Debt to Equity Ratio | 0.0764 |
| Current Ratio | 5.278 |
| Net Debt Paydown Yield | 0.01% |